Abstract:The causal association between lipidomic profiles and intracranial aneurysm (IA) risk remains unclear. This two‐sample Mendelian randomization (MR) study demonstrated that five lipidomic profile components were found to have significant causal associations with the risk of IA and aneurysmal subarachnoid hemorrhage (aSAH). Moreover, the effect of serum lipids on IA and aSAH may be mainly caused by subclasses of lipids such as VLDL and fatty acids. This study may provide a comprehensive analysis of the causal relationship between lipid profiles and IA risk. A two‐sample Mendelian randomization (MR) analysis was utilized to assess the causal relationship between lipidomic profiles and the risk of intracranial aneurysms (IAs). Genetic variants related to lipidomic profiles (227 components) and IA [IA, aneurysmal subarachnoid hemorrhage (aSAH) only, unruptured IA (uIA) only] were obtained from published genome‐wide association studies (GWASs) or the IEU Open GWAS project and used as instrumental variables for MR analysis. The inverse‐variance weighted method was used in the primary analyses to derive causality estimates and was expressed as odds ratio (OR) with 95% confidence interval (CI). Of these 227 lipidomic profiles, only genetically predicted high levels of cholesterol to total lipids ratio in very small very‐low‐density lipoproteins (VLDL) [OR = 0.629 (95% CI, 0.504–0.786)], cholesteryl esters to total lipids ratio in very small VLDL [OR = 0.637 (95% CI, 0.509–0.797)], ratio of docosahexaenoic acid to total fatty acids [OR = 0.691 (95% CI, 0.582–0.820)], and ratio of polyunsaturated fatty acids to monounsaturated fatty acids [OR = 0.630 (95% CI, 0.522–0.760)] reduced the risk of aSAH, whereas genetically predicted high ratio of monounsaturated fatty acids to total fatty acids [OR = 1.471 (95% CI, 1.215–1.781)] increased the risk of aSAH. Moreover, genetically predicted high levels of cholesterol to total lipids ratio in very small VLDL [OR = 0.657 (95% CI, 0.542–0.798)], cholesteryl esters to total lipids ratio in very small VLDL [OR = 0.663 (95% CI, 0.548–0.803)], free cholesterol to total lipids ratio in small VLDL [OR = 0.682 (95% CI, 0.560–0.832)], phospholipids to total lipids ratio in small VLDL [OR = 0.674 (95% CI, 0.548–0.830)], and ratio of polyunsaturated fatty acids to monounsaturated fatty acids [OR = 0.678 (95% CI, 0.569–0.808)] reduced the risk of IA. The results of multivariable MR demonstrated that these causal associations persisted after adjusting for systolic blood pressure and cigarettes smoked per day. The effect of serum lipids on IA and aSAH may be mainly caused by subclasses of lipids such as VLDL.

Lipids, Apolipoproteins, Statins, and Intracerebral Hemorrhage: A Mendelian Randomization Study

Lipids, Apolipoproteins, Lipid-Lowering Drugs, and the Risk of Cerebral Small Vessel Disease: A Mendelian Randomization Study

Novel Insights into Causal Effects of Serum Lipids, Lipid Metabolites, and Lipid-Modifying Targets on the Risk of Intracerebral Aneurysm.

Genetically Elevated LDL Associates with Lower Risk of Intracerebral Hemorrhage

Associations of lipids and lipid-lowering drugs with risk of stroke: a Mendelian randomization study

Association of serum lipidomic profiles with risk of intracranial aneurysm: A Mendelian randomization study

Association between Lipid-Lowering Drugs and Traumatic Subdural Hemorrhage: A Mendelian Randomization Study

Association between Lipid Levels and Risk for Different Types of Aneurysms: A Mendelian Randomization Study

Genetic analyses identify brain imaging-derived phenotypes associated with the risk of intracerebral hemorrhage

Associations of Lipids and Lipid-Lowering Drugs with Risk of Vascular Dementia: A Mendelian Randomization Study

Lipids, lipid-lowering agents, and inflammatory bowel disease: a Mendelian randomization study

Genetic causality of lipidomic and immune cell profiles in ischemic stroke

Evaluating the Causal Effects of Low Density Lipoprotein Cholesterol Levels on Ischemic Stroke: A Mendelian Randomization Study

LDL-c Lowering, Ischemic Stroke, and Small Vessel Disease Brain Imaging Biomarkers: A Mendelian Randomization Study

Genetically predicted small dense low-density lipoprotein cholesterol and ischemic stroke subtype: multivariable Mendelian randomization study

Cardiac Troponin I and Risk of Stroke A Mendelian Randomization Study

Association of lipids and lipid-lowering drugs with peripheral arterial disease: A Mendelian randomization study

Risk Factors for Intracerebral Hemorrhage: Genome-Wide Association Study and Mendelian Randomization Analyses

Causal association of blood lipids with all-cause and cause-specific mortality risk: a Mendelian randomization study

Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study

Genetic loci for serum lipid fractions and intracerebral hemorrhage